Endometrial Carcinoma — Trials

Endometrial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

325 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 109
Recruiting: 52
Ph III recruiting: 4
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01939028	Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery	terminated	N/A	58	Case Comprehensive Cancer CenterOTHER	1	Aug 27, 2020	clinicaltrials
NCT00070317	Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer	terminated	N/A	102	Gynecologic Oncology GroupNETWORK	1	Nov 6, 2017	clinicaltrials